Proposed 340B rebate model generates an array of concerns among providers
BY Nick Hut, Senior Reporter, HFMA Hospital advocates are pushing back on a fast-approaching rebate model for the 340B Drug Pricing Program, while a new Congressional Budget Office (CBO) report illustrates the accelerating spending in the program. The Health Resources and Services Administration (HRSA), which administers 340B, previously announced that a pilot program to test the application of a rebate model would begin Jan. 1, 2026. Comments on the model, which initially is set to...











